TARSUS PHARMACEUTICALS, INC. (TARS) Operating cash flow 2019–2025
TARSUS PHARMACEUTICALS, INC. (TARS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.5MFY2025 · since FY2019: -$3.7M → -$12.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.5M | +85.0% |
| FY2024 | -$83.0M | +29.3% |
| FY2023 | -$117.5M | -139.6% |
| FY2022 | -$49.0M | -1408.2% |
| FY2021 | $3.7M | +117.7% |
| FY2020 | -$21.1M | -475.5% |
| FY2019 | -$3.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice